Martinez D, Lukasewycz O A, Murphy W H
J Immunol. 1975 Sep;115(3):724-9.
The relative suppressive effects of x-irradiation (XR), cyclophosphamide (CY), prednisolone (PRD), and methotrexate (MTX) on the primary and secondary cellular immune response of C58/wm mice to syngeneic line Ib transplantable leukemia (Ib cells) were quantified. An LD10 dose of each agent was used for immunosuppression. XR, CY, and PRD were markedly suppressive for the primary immune response if given 24 hr before mice were immunized to Ib cells but less immunosuppressive if given 24 hr later. MTX was only slightly immunosuppressive XR, CY, and PRD also suppressed the secondary immune response if given before but not after antigen. The immunosuppressive effect of these agents was evaluated by defining their median immunosuppressive dose or the median time in days required for mice to recover from graded doses of each immunosuppressive agent. For example, the median recovery time from an LD10 of XR, CY, and PRD was 29.3, 19.7, and 3.7 days, respectively. Immunologic competence remaining after XR or drug treatment was quantified in terms of the LD50 dose of Ib cells required to kill recipient mice. For XR, CY, PRD, and MTX it was 10(6.16), 10(2.15), 10(6.90) and greater than 10(7.0) viable Ib cells, respectively. The overall results provided evidence that the primary and secondary cellular immune responses to a weak syngeneic tumor antigen were resistant to immunosuppression once they were initiated. There was a good correlation between the relative immunosuppressive effect of the test agents and the amount that they reduced the number of immune spleen cells. The agents also impaired the immunocompetence of individual spleen cells. Mechanisms by which XR or drugs might exert their immunosuppressive effects were discussed.
对X射线照射(XR)、环磷酰胺(CY)、泼尼松龙(PRD)和甲氨蝶呤(MTX)对C58/wm小鼠针对同基因Ib型可移植白血病(Ib细胞)的初次和二次细胞免疫反应的相对抑制作用进行了定量分析。每种药物的LD10剂量用于免疫抑制。如果在小鼠接种Ib细胞前24小时给予XR、CY和PRD,则对初次免疫反应有明显抑制作用,但如果在24小时后给予,则免疫抑制作用较弱。MTX仅有轻微的免疫抑制作用。XR、CY和PRD如果在抗原之前而非之后给予,也会抑制二次免疫反应。通过确定它们的中位免疫抑制剂量或小鼠从不同剂量的每种免疫抑制剂中恢复所需的中位天数来评估这些药物的免疫抑制效果。例如,从XR、CY和PRD的LD10剂量中恢复的中位时间分别为29.3天、19.7天和3.7天。根据杀死受体小鼠所需的Ib细胞LD50剂量对XR或药物治疗后剩余的免疫能力进行了定量分析。对于XR、CY、PRD和MTX,分别为10(6.16)、10(2.15)、10(6.90)和大于10(7.0)个活的Ib细胞。总体结果表明,针对弱同基因肿瘤抗原的初次和二次细胞免疫反应一旦启动就对免疫抑制具有抗性。受试药物的相对免疫抑制作用与其减少免疫脾细胞数量的程度之间存在良好的相关性。这些药物还损害了单个脾细胞的免疫能力。讨论了XR或药物可能发挥其免疫抑制作用的机制。